|
Variables
|
B
|
S.E,
|
P value
|
RR
|
95 % C.I.
|
|---|
|
Upper
|
Lower
|
|---|
|
R0
|
|
Neoadjuvant chemotherapy
|
−1.004
|
0.367
|
0.006
|
0.366
|
0.178
|
0.752
|
|
ASA score
|
0.772
|
0.314
|
0.014
|
2.165
|
1.170
|
4.006
|
|
Bowel mesenteric carcinomatosisc
|
0.718
|
0.323
|
0.026
|
2.051
|
1.008
|
3.866
|
|
R0.5
|
|
Neoadjuvant chemotherapy
|
−0.907
|
0.301
|
0.003
|
0.404
|
0.224
|
0.729
|
|
ECOG performance
|
0.639
|
0.190
|
0.001
|
1.895
|
1.307
|
2.747
|
- B beta coefficient, SE standard error, RR relative risk, 95 % CI 95 % confidence interval, R0 complete cytoreduction, R0.5 cut-off point of residual disease in overall all was 0.5 cm, ASA American Society of Anesthesiologists, ECOG Eastern Cooperative Oncology Group
- aLogistic regression analysis
- b Variable “surgical team” was the most significant determinant of surgical outcomes, but it was not included into this model
- c It is a variable found in surgery, but interestingly, it is a predictor of complete cytoreduction not the predictor of small residual disease of 0.5 cm, so it was included in the Logistic regression model
